![]() |
Major applications |
AP-3000 is based on SPR(Surface Plasmon Resonance) technology, and is a label free screening system for drug discovery. It is the world fastest (3,840 compounds/day)*1 system of its kind, and has high sensitivity to detect small molecular weight compounds. *1: Information available in the market as of June, 2007. The throughput depends on assay protocols. |
| [1]Fragment screening |
FBDD (Fragment-based Drug Discovery) is a new drug discovery method to find fragment compounds which bind to target proteins, and to optimize them to make lead compounds. Fragment compounds have simple structures, small molecular weight, and low affinity. |
|
|
AP-3000 has the following unique properties and a best system suited for fragment screening. |
|
|
Fragment screening is carried out as follows. |
|
Day 1 |
(1)Optimization of protein immobilization conditions (6 conditions): |
|
Day 2 |
(2)3,840 compounds prescreening*1: |
3,840 dp*2 |
Day 3 |
(2)3,840 compounds prescreening: |
3,840 dp |
Day 4 |
(2)3,840 compounds prescreening: |
3,840 dp |
Day 5 |
(3)3,840 compounds Main screening*1: |
3,840 dp |
Day 6 |
(3)3,840 compounds Main screening: |
3,840 dp |
Day 7 |
(3)3,840 compounds Main screening: |
3,840 dp |
Day 8 |
Review of main screening results/ preparation of analyte plates for dose response. |
|
Day 9 |
(4)120 Compounds Dose response: |
1,920 dp |
Day 10 |
(4)120 Compounds Dose response: |
1,920 dp |
Day 11 |
(4)120 Compounds Dose response: |
1,920 dp |
Day 12 |
(4)120 Compounds Dose response: |
1,920 dp |
Day 13 |
(4) 96 Compounds Dose response: |
1,536 dp |
Day 14 |
Review of dose response measurement results. |
Total 32,256 dp |
*1 |
Pre-screening: screening to see how a compound library behaves |
*2 |
dp:data points |
*3 |
The hit rate is 5%, and the dose response of hit compounds is done at 8 points x n=2 per one compound. |
Day 1 |
(1)Optimization of protein immobilization conditions(6 conditions): |
|
Day 2 |
(2)2,304 compounds Prescreening: |
2,304 dp |
Day 3 |
(3)2,304 compounds Main screening: |
2,304 dp |
Day 4 |
Review of main screening results/ preparation of analyte plates for dose response. |
|
Day 5 |
(4)115 Compounds dose response: |
1,840 dp |
Day 6 |
Review of dose response measurement results. |
Total 6,448 dp |
It is required to measure multiple compounds repeatedly at the same area of protein immobilization in order to minimize protein consumption. However, if there are strong nonspecific binding compounds, ordinary washing does not do thorough dissociation, and measurements of the compounds that follow those nonspecific binders get affected, causing incorrect binding signals for them. Therefore it is recommended to do prescreening to eliminate nonspecific binding compounds before the main screening. |
||
AP-3000 has the capability to skip injection of specific compounds on analyte plates into sensors. Using this function, the compounds which the prescreening identifies as those not to be further measured do not get injected into the flow paths in sensors and therefore will not be measured. Accordingly, analyte plates for the prescreening and those for the main screening are exactly same, and therefore reconstructing of plates is not necessary. This makes preparation of analyte plates simple and easy. |
||
| [2]Random screening |
SPR methods have not been used for the random library screening because of their low throughput. AP-3000 changes this, and makes SPR well suited for the random library screening, because of the following reasons: |
|
|
- High throughput ( Maximum of 3,840 compounds/day) |
|
|
Label free binding assays by AP-3000 do not require building of complicated assay protocols. Therefore, this widely increases a range of target proteins to select from.
Even when measurements cannot be completed within one day because of the library size being large, it is possible to plan ahead using AP-3000 Planner Software. With this software, the number of days, and the amount of consumables, reagents, and buffers, which are required for a full process of the screening can be planned, prior to the screening, |
|
![]() |
|
| [3]Focused library screening |
In recent years, screening with a library focused on each target protein has become popular. AP-3000 is well suited for the focused library screening because of the following reasons. |
|
|
For instance, when screening is done on a focused library targeting proteins such as kinase, the target protein sometimes loses its activity at the time of immobilization. It is possible to confirm if or not there is a loss of activity by measuring the binding between the immobilized protein and positive control compounds. But still there is a possibility of nonspecific binding taking place between positive control compounds and the protein which has lost activity or been denatured. |
|
At the same time, using the data mining software, Spotfire DecisionSite for AP-3000, the following can be automatically calculated: |
![]() |
| [4]Secondary screening |
For the secondary screening, the hit rate is extremely high because the compounds have been already identified as hit compounds by the random screening, and therefore there is a large possibility for these compounds to include tight binders. |
|
|
It is required to measure multiple compounds repeatedly at the same area of protein immobilization in order to minimize protein consumption. However, if there are tight binders, ordinary washing does not do thorough dissociation, and measurements of the compounds that follow those tight binders get affected, causing incorrect binding signals for them. Therefore it is recommended to do prescreening to eliminate tight binders before the secondary screening. |
|
| [5]Screening of antibodies |
AP-3000's sensor is made of the flow-paths and prisms all combined together.
AP-3000 has following properties and because of them, it is good for screening of antibodies. |
|
|
Especially since the flow-path is wide and short, crude samples injected do not clog up the path, and even when the path gets clogged up, it is easy for a user to replace it with a new one by simply changing the disposable sensor. Thus measurement can be restarted right away, because the vender's services are not required. |
|
| [6]Screening of In Silico derived compounds |
As computing technology advances, there is an increasing trend to do In-Silico screening of a virtual library based on the idea of SBDD(Structure Based Drug Design). Because of the following properties, AP-3000 is ideally suited for screening of In-Silico derived compounds. |
|
|
By combining In Silico screening and direct binding assays on AP-3000, real binders for target proteins, which have not been previously available, can be found efficiently. |
|
| [7]Screening of blood plasma |
Because of the following properties, AP-3000 is applicable to screening plasma samples from living bodies. |
|
|
Measurements are fully automated, which allows expansion of experiments capacity. |
|
| [8]Screening of agricultural compound library |
AP-3000 is well suited for binding assays of agricultural compound library. |
|
Because of these features, even if precipitated compounds go through, they do not clog up the flow-paths, and should the flow paths get clogged up, users can solve the problem simply by replacing the sensors without the vender services. Thus flexibility for experiments is increased. |
|